Get 50% OFF This Summer!

Advertisement
logo

Max Healthcare Institute

MAXHEALTH
Large Cap
(%) 1D
1D1W1M3M6M1YMAX

Investor Sentiment

50%50%
Bullish
Bearish
Advertisement

Max Healthcare Institute Share price and Fundamental Analysis

View All Details
View All Details
Max Healthcare Institute Limited was originally incorporated as 'Infinitum Technologies Private Limited' at New Delhi, India as a Private Limited Company dated June 18 ,2001. Pursuant to a Fresh Certificate of Incorporation dated June 28, 2002, the name of Infinitum Technologies Private Limited' was changed to Max Healthcare Institute Private Limited'. Thereafter, pursuant to a Special Resolution dated May 16, 2002 and a fresh Certificate of Incorporation dated October 18, 2002, the Company converted to a Public Limited, and name was changed to Max Healthcare Institute Limited'. The Company is primarily engaged in provision of healthcare services through primary care clinics, multi speciality hospitals / medical centres and superspeciality Hospitals facilities.
Company Incorporation2001
ChairmanAbhay Soi
Head QuartersNA
Previous NameNA

Key Metrics

Market Cap (Cr)
1,09,555
PE Ratio
103.3
Industry P/E
63.46
PEG Ratio
336.33
ROE
12.03%
ROCE
13.27%
ROA
7.68%
Total Debt (Cr)
1,768.19
Debt to Equity
0.2
Dividend Yield
0.13%
EPS
10.91
Book Value & P/B
90.51 x 12.45
Face Value
10
Outstanding Shares(Cr)
97.21
Current Ratio
1.45
EV to Sales
16.57

Included In

Nifty Midcap 100Index
Nifty Services SectorIndex
S&P BSE 500Index
S&P BSE HealthcareIndex
+More

Stock Returns

1 Week+2.02%
1 Month-1.01%
6 Months+8.47%
1 Year+37.02%
3 Years+204.94%
5 Years+894.9%

CAGR

1 Year CAGR

Revenue Growth

+18.49%

Net Profit Growth

-4.16%

Operating Profit Growth

+21.05%

Dividend Growth

+50%

Stock Returns CAGR

+40.87%
no_data

No Stocks

Smart Score

2.6
icn

Unlock Smart Score

See Detailed Analysis & Insights

icn

Unlock Insights

See Detailed Analysis & Insights

Technicals

Returns Calculator

If you would have invested
In 5 years the current value would be
NaNCRNaNCR( %)

Research Report

No Research Report

View Other Reports >

Corporate Action

Board-Meetings
Board-Meetings
Dividends
Bonus
Splits
Right-issues
AGM-EGM
Bulk-Deal
Block-Deal

Financials

Half Yearly Statement

/ View Standalone

Profit and Loss Statement

/ View Standalone
Credit Rating
Director Report
Chairman Report
Auditor Report

Balance sheet

/ View Standalone

Cashflow Statement

/ View Standalone
Mar 25

Promoters : 23.74%

FIIs : 54.74%

DIIs : 17.58%

Public : 3.94%

Promoter
FII/FPI
DII
Public
Promoter Pledge stands at 0.0% of holding in March 2025 Qtr
DII Shareholding Increased by 2.03% to 17.58% in March 2025 Qtr
FII Shareholding Decreased by 2.19% to 54.74% in March 2025 Qtr

Top Shareholders

View all Share Holders

Key Ratios

Profitability
Valuation
Liquidity

ROE

Avg ROE (3 Yrs) : NaN%

ROCE

Avg ROCE (3 Yrs) : NaN%

ROA

Avg ROA (3 Yrs) : NaN%

NPM

Avg NPM (3 Yrs) : NaN%

Dividend History

No data

Max Healthcare Institute Competitors

Sector
Industry

Company Name

MCap(TTM)

PE(TTM)

P/B(TTM)

ROE(TTM)

D/E

Current Ratio(TTM)

No data

5 Year FactSheet

Profitability
Profitability
Growth Ratios
Valuation Ratios
Cashflow Ratios
Debt and Liquidity
Efficiency Ratios
No data

Documents

Annual Reports
Con-Call

News

Max Healthcare Institute Management and History

Company Management

icn

Unlock Management Data

See Detailed Analysis & Insights

Company History

Max Healthcare Institute Limited was originally incorporated as 'Infinitum Technologies Private Limited' at New Delhi, India as a Private Limited Company dated June 18 ,2001. Pursuant to a Fresh Certificate of Incorporation dated June 28, 2002, the name of Infinitum Technologies Private Limited' was changed to Max Healthcare Institute Private Limited'. Thereafter, pursuant to a Special Resolution dated May 16, 2002 and a fresh Certificate of Incorporation dated October 18, 2002, the Company converted to a Public Limited, and name was changed to Max Healthcare Institute Limited'. The Company is primarily engaged in provision of healthcare services through primary care clinics, multi speciality hospitals / medical centres and superspeciality Hospitals facilities.

The Company is a leading hospital chains in India with major concentration in North India consisting of a network of 13 network healthcare facilities, which includes BLK Hospital and BNH Hospital. Besides, it provides healthcare services across secondary and tertiary care specialties with key focus on centres of excellence i.e., oncology, neurosciences, cardiac sciences, orthopaedics,renal sciences, liver and biliary sciences and minimal access metabolic and bariatric surgery (MAMBS).In addition to core hospital business, the company has two SBUs, namely, MaxHome and MaxLab. MaxHome is a platform that provides health and wellness services at home. It has 12 service lines, including pathology, pharmacy delivery, physiotherapy and critical care nursing. MaxLab offers pathology services to patients outside of hospitals through a variety of channels including third party hospital laboratory management. Eight hospitals and five medical centres are located in Delhi and the NCR, and the others are located in cities of Mumbai, Mohali, Bathinda and Dehradun. They provide diagnostic, pathology, radiology, radiation oncology and clinical services in select specialties/ departments through deployment of doctors and other medical staff in 4 Partner Healthcare Facilities.In addition, it has established a representative office in Nairobi, Kenya under the name True Max Healthcare' which helps in partnering with local hospitals, conducting OPDs, assisting the potential patients with medical visas and pre - travel preparation and participating in local events to build its brand internationally.

In the year 2000, the Company opened first Medcentre with out-patient facilities and day care surgeries at Max Medcentre, Panchsheel Park.

In the year 2002, there were facilities opened in Pitampura and Noida subject to hospital in Pitampura became the first ISO certified hospital for high-end secondary care.

In 2004, the Company opened its first super tertiary care facility with advanced cardiac life support ambulances and air evacuation service at Max Heart & Vascular Institute, Saket.

In 2005, multi-speciality tertiary care centre in East Delhi with 147 beds, three operation theatres and 1 cardiac catheterization laboratory at Max Hospital, Patparganj were opened by the Company.

In 2006, there was opening of first super speciality tertiary care location at Max Super Speciality Hospital Saket.

The Company received NABH and NABL certification for laboratories and simultaneously opened a high-end secondary care hospital at Gurgaon in the year of 2007.

The BLK Hospital was redeveloped and re-launched as a multi super speciality facility by the Company in 2009.

On 05 August 2009, through a concession agreement, the Company entered into a public private partnership (PPP) with the Department of Health and Family Welfare (DHFW), Government of Punjab and HBPL (Hometrail Buildtech Private Limited), the Company's subsidiary merged with HEPL (Hometrail Estate Private Limited), for development of greenfield super speciality hospital in Bathinda, Punjab, which was engaged in the development of greenfield super speciality hospital in Mohali, Punjab.

In 2010, the BLK Hospital received NABH accreditation and therby the Company opened a 300 bedded hospital in Shalimar Bagh.

In 2011, the Company thru HBPL, extended its footprint in North India through a public private partnership with State Government of Punjab with setting up of hospitals in Mohali and Bathinda.

In 2012, the first super speciality hospital in Uttarakhand, Max Super Speciality Hospital, Dehradun was opened and the Company's BLK Hospital installed Asia Pacific regions' first cyber-knife VSI - an ultra modern latest generation PET-CT to aid accurate diagnosis.

In 2013, the BLK Hospital commenced liver and kidney transplant services. Max Healthcare successfully performed 100 bone marrow transplant surgeries within a span of 24 months and landmark surgery on separating two conjoint Nigerian twins respectively.

On 28 May 2015, the Company acquired controlling stake in Crosslay Remedies Limited (CRL), a subsidiary that owns and operates a 378 bedded hospital with 328 operational beds, located in East Delhi-Ghaziabad-Noida corridor. The Company further had acquired 51% stake in Saket City Hospitals Private Limited, a subsidiary of the Company (SCHPL), pursuant to which it became a subsidiary in 2015.

In 2016, the company launched its vertical, Max@Home, Max Lab and India's first oncology day-care center at Lajpat Nagar to provide chemotherapy to oncology patients outside the hospital, first standalone immigration center at Lajpat Nagar, New Delhi, the Responder-on-Bike initiative, Max Centre for Liver and Biliary Sciences and oncology dedicated wing in Max Hospital Shalimar Bagh.

In 2017, Max Super Speciality Hospital, Shalimar Bagh introduced advanced silent MRI and intraoperative and portable CT scanner with navigation, it became the first hospital in the network to get accredited by the Joint Commission International (JCI).

The Company incorporated MHC Global Healthcare (Nigeria) Limited (MGHL) in Lagos, Nigeria as a wholly owned subsidiary on May 20, 2019.

The Hon'ble National Company Law Tribunal, Mumbai Bench (NCLT) vide its order dated January 17, 2020 sanctioned the Composite Scheme of Amalgamation and Arrangement amongst erstwhile Max India Limited, the Company, Radiant, Max India Ltd. (formerly known as Advaita Allied Health Services Limited) and their respective shareholders and creditors and the Scheme was effective from June 1, 2020. Subsequent to the effective date, healthcare business of Radiant was demerged into the Company and also, residual erstwhile Max India Ltd. (i.e. post demerger of allied health and associated services into Advaita Allied Health Services Limited) which comprises of healthcare activities amalgamated with the Company. Post demerger and amalgamation, the Company became the second largest healthcare delivery chain in India (considering only income from healthcare services aggregated for Company, Radiant and Partner Healthcare Facilities). Further, pursuant to the Scheme, equity shares of the Company were listed on the BSE Limited and National Stock Exchange of India Limited (NSE) on August 21, 2020.

As on March 31, 2021, the Company has 6 subsidiaries.

The current Promoters of the Company are Mr. Analjit Singh, Ms. Neelu Analjit Singh, Ms. Piya Singh, Mr. Veer Singh, Ms. Tara Singh Vachani, MVIHPL, Mr. Abhay Soi and Kayak Investments Holding Pte. Ltd. Pursuant to Scheme, Analjit Singh Group is to be reclassified as public shareholders in accordance with the provisions of the Listing Regulations (such reclassification, the Depromoterisation). Such Depromoterisation will be undertaken only upon the Company achieving the MPS requirement as prescribed under the SCRR. Post such Depromoterisation, Mr. Abhay Soi and Kayak shall be the Promoters of the Company.

During the year 2022, the Company acquired 26% stake in Eqova Healthcare Private Limited to expand its network footprint in East Delhi with addition of 400 beds on February 10, 2022. It also entered into a long term exclusive Operation and Management Agreement with Muthoot Hospitals Private Limited for an upcoming hospital at Dwarka, New Delhi on January 20, 2022. On October 4, 2021, the Company purchased two parcels of land admeasuring ~ 5.26 acres and ~ 6.11 acres, in Gurugram, Haryana on freehold basis for setting up two hospitals and expand the bed capacity of the Company in NCR region by ~1000 beds.

Kayak Investments Holding Pte. Limited, one of the Promoters of the Company sold 27,26,754 equity shares and consequent to the open market sale, it complied with the MPS norms within the prescribed timelines i.e. with effect from August 20, 2021. As a result, at the end of FY 21-22, the public shareholding in the Company stood at 49.36%.

Pursuant to Composite Scheme of Amalgamation and Arrangement amongst erstwhile Max India Limited, the Company, Radiant Life Care Private Limited, Max India Limited (formerly known as Advaita Allied Health Services Limited) and their respective shareholders and creditors effective from June 1, 2020, certain persons / entity belonging to Promoter / Promoter Group of the Company i.e. Max Ventures Investment Holdings Private Limited, Mr. Analjit Singh, Ms. Piya Singh, Ms. Neelu Analjit Singh, Ms. Tara Singh Vachani and Mr. Veer Singh have been re-classified as Public Category with the approval accorded by stock exchanges viz. BSE Limited and National Stock Exchange of India Limited (NSE) vide their letters dated March 24, 2022. Therefore, 4,06,229 equity shares of the Company held by the above Promoter/ Promoter Group in aggregate, representing 0.04% of its total issued and paid up capital at that time, have been re-classified into Public' from Promoters / Promoter Group' category with effect from March 24, 2022. Subsequent to re-classification of Promoter / Promoter Group, the Company has only 2 Promoters i.e. Mr. Abhay Soi and Kayak.

The Company commissioned 92-bedded Oncology Block at Max Super Speciality Hospital, in Shalimar Bagh in March, 2023. In 2023, a cloud deployment was undertaken for two key locations, including Max Lajpat Nagar and Max Panchsheel. During FY23, Max@Home, with the vision of Digital First', launched Instant Doctor Consultation service.

Max Healthcare Institute Share Price

Max Healthcare Institute share price reflects investor sentiment toward the company and is impacted by various factors such as financial performance, market trends, and economic conditions. Share price is an indicator which shows the current value of the company's shares at which buyers or sellers can transact.

Max Healthcare Institute Market Cap

Market capitalization of Max Healthcare Institute indicates the total value of its outstanding shares. Marketcap is calculated by multiplying share price and outstanding shares of the company. It is a helpful metric for assessing the company's size and market Valuation. It also helps investors understand how Max Healthcare Institute is valued compared to its competitors.

Max Healthcare Institute PE Ratio

Max Healthcare Institute PE ratio helps investors understand what is the market value of each stock compared to Max Healthcare Institute 's earnings. A PE ratio higher than the average industry PE could indicate an overvaluation of the stock, whereas a lower PE compared to the average industry PE could indicate an undervaluation.

Max Healthcare Institute PEG Ratio

The PEG ratio of Max Healthcare Institute evaluates its PE ratio in relation to its growth rate. A PEG ratio of 1 indicates a fair value, a PEG ratio of less than 1 indicates undervaluation, and a PEG ratio of more than 1 indicates overvaluation.

Max Healthcare Institute ROE (Return on Equity)

Return on Equity (ROE) measures how effectively Max Healthcare Institute generates profit from shareholders' equity. A higher ROE of more than 20% indicates better financial performance in terms of profitability.

Max Healthcare Institute ROCE (Return on Capital Employed)

Return on Capital Employed (ROCE) evaluates the profitability of Max Healthcare Institute in relation to its capital employed. In simple terms, ROCE provides insight to investors as to how well the company is utilizing the capital deployed. A high ROCE of more than 20% shows that the business is making profitable use of its capital.

Max Healthcare Institute Total Debt

Total debt of Max Healthcare Institute shows how much the company owes to either banks or individual creditors. In simple terms, this is the amount the company has to repay. Total debt can be a very useful metric to show the financial health of the company. Total debt more than equity is considered to be a bad sign.

Max Healthcare Institute Debt to Equity Ratio

The Debt-to-Equity (DE) ratio of Max Healthcare Institute compares its total debt to shareholders' equity. A higher Debt to Equity ratio could indicate higher financial risk, while a lower ratio suggests that the company is managing its debt efficiently.

Max Healthcare Institute CAGR (Compound Annual Growth Rate)

CAGR shows the consistent growth rate of Max Healthcare Institute over a specific period, whether it is over a month, a year, or 10 years. It is a key metric to evaluate the company’s long-term growth potential. Main metrics for which CAGR is calculated are net sales, net profit, operating profit, and stock returns.

Max Healthcare Institute Technical Analysis

Technical analysis of Max Healthcare Institute helps investors get an insight into when they can enter or exit the stock. Key components of Max Healthcare Institute Technical Analysis include:

Support Levels (S1, S2, S3)

There are usually multiple support levels, but the main support levels for a stock are S1, S2, S3. Support levels indicate price points where stock might get support from buyers, helping the stock stop falling and rise.

Resistance Levels (R1, R2, R3)

There are usually multiple resistance levels, but the main resistance levels for a stock are R1, R2, R3. Resistance levels represent price points where Max Healthcare Institute shares often struggle to rise above due to selling pressure.

Max Healthcare Institute Dividends

Dividends refer to the portion of the company’s profits distributed to its shareholders. Dividends are typically paid out in cash and reflect Max Healthcare Institute ’s financial health and profitability.

Max Healthcare Institute Bonus Shares

Bonus shares are usually given by companies to make the stock more affordable, increase liquidity, boost investor confidence, and more.

Max Healthcare Institute Stock Split

Stock split increases the number of its outstanding shares by dividing each existing share into multiple shares. When the company offers a stock split, the face value of the stock reduces in the same proportion as the split ratio.

Max Healthcare Institute Financials

The financials of Max Healthcare Institute provide a complete view to investors about its net sales, net profit, operating profits, expenses, and overall financial health. Investors can analyze financial data to assess the company’s stability and also understand how the company has been growing financially.

Max Healthcare Institute Profit and Loss Statements

The profit and loss statement of Max Healthcare Institute highlights its net sales, net profit, total expenditure, and operating profits in the current financial year. This Profit and Loss statement is crucial for evaluating the profitability and financial stability of Max Healthcare Institute .

Max Healthcare Institute Balance Sheet

The balance sheet presents a snapshot of Max Healthcare Institute ’s assets, liabilities, and equity of shareholders, providing insights into the financials of the company.

Max Healthcare Institute Cashflow Statements

Cashflow statements track the company's cash inflows and outflows over a period. It is an essential tool for understanding how well the company manages its liquidity and finances.

Download the App